GlassScriptPhysician profile
Syed Arman Raza
NPI 1134153794
$11,801.71
in general payments reported to CMS, 2019-2025
34 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $602 · 2021: $1,428 · 2022: $1,432 · 2023: $1,297 · 2024: $4,902 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,622 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Education: $44.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,622.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Education | $44.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,501.83 | 2020-2025 | Aveir, Confirm Rx, Gallant |
| Medtronic, INC. | $3,486.48 | 2021-2025 | Venaseal, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $848.85 | 2020-2025 | Varithena Administration Pack, Watchman Flx, Watchman Access System |
| Impulse Dynamics (USA) INC. | $606.34 | 2022-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.25 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $370.70 | 2019-2024 | Xarelto |
| Biotronik INC. | $334.19 | 2019-2022 | |
| Novo Nordisk INC | $333.66 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $332.16 | 2022-2024 | Repatha |
| Medtronic Vascular, INC. | $157.86 | 2019-2020 | |
| Penumbra, INC. | $147.82 | 2019 | |
| Philips North America LLC | $145.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $112.49 | 2021-2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $101.55 | 2024 | Assure Wcd |
| Tactile Systems Technology INC | $95.05 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $93.95 | 2021 | |
| Imperative Care, INC | $80.45 | 2025 | Symphony Catheter |
| Inspire Medical Systems, INC. | $71.75 | 2024 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $58.54 | 2022-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $39.10 | 2019-2024 | |
| Shockwave Medical, INC | $37.48 | 2021 | |
| Venclose INC. | $35.57 | 2019 | |
| Bard Peripheral Vascular, INC. | $34.98 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $28.57 | 2021 | |
| Recor Medical INC | $26.07 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abiomed | $23.97 | 2024 | Impella |
| Esperion Therapeutics, INC. | $22.08 | 2024 | Nexletol |
| Cvrx, INC. | $22.01 | 2024 | Barostim Neo System |
| Cashflow Solutions, LLC | $21.52 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Itamar Medical INC | $11.76 | 2021 | |
| Amarin Pharma, INC. | $11.38 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.01 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $8.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.